IE811074L - Sulphated polysaccharides - Google Patents

Sulphated polysaccharides

Info

Publication number
IE811074L
IE811074L IE811074A IE107481A IE811074L IE 811074 L IE811074 L IE 811074L IE 811074 A IE811074 A IE 811074A IE 107481 A IE107481 A IE 107481A IE 811074 L IE811074 L IE 811074L
Authority
IE
Ireland
Prior art keywords
percentage
mixtures
degrees
polysaccharides
sulphated polysaccharides
Prior art date
Application number
IE811074A
Other versions
IE51283B1 (en
Original Assignee
Pharmuka Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9241965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IE811074(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmuka Lab filed Critical Pharmuka Lab
Publication of IE811074L publication Critical patent/IE811074L/en
Publication of IE51283B1 publication Critical patent/IE51283B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

1. Mixtures of sulphated polysaccharides having the general structure of the polysaccharides present in heparin, whose acid groups are in the free form or converted into a salt form, characterised in that the polysaccharides present in the said mixtures have an ethylenic double bond at one of the ends of their chain and in that, in the form of the sodium salt, the mixtures have the following characteristics : - percentage of sulphur : 9% to 13.5% - percentage of nitrogen : 1.8% to 2.5% - percentage of uronic acids : 20% to 30% - weight-average molecular weight : 2000 to 10 000 daltons - specific rotatory power in aqueous solution at 20 degrees C : [alpha]D-20 = + 25 degrees to + 55 degrees [EP0040144A1]
IE1074/81A 1980-05-14 1981-05-13 Sulphated polysaccharides,processes for their preparation and their use as medicaments IE51283B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8010791A FR2482611B1 (en) 1980-05-14 1980-05-14 NOVEL SULFATED POLYSACCHARIDES, METHODS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS

Publications (2)

Publication Number Publication Date
IE811074L true IE811074L (en) 1981-11-14
IE51283B1 IE51283B1 (en) 1986-11-26

Family

ID=9241965

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1074/81A IE51283B1 (en) 1980-05-14 1981-05-13 Sulphated polysaccharides,processes for their preparation and their use as medicaments

Country Status (23)

Country Link
EP (1) EP0040144B1 (en)
JP (1) JPS6051482B2 (en)
KR (1) KR840001753B1 (en)
AR (1) AR229510A1 (en)
AT (1) AT384428B (en)
AU (1) AU535791B2 (en)
CA (1) CA1181744A (en)
DE (1) DE3165361D1 (en)
DK (1) DK168824B1 (en)
DZ (1) DZ294A1 (en)
ES (1) ES502199A0 (en)
FI (1) FI67865C (en)
FR (1) FR2482611B1 (en)
GR (1) GR82283B (en)
HU (1) HU188667B (en)
IE (1) IE51283B1 (en)
IL (1) IL62866A (en)
IN (1) IN152828B (en)
MA (1) MA19143A1 (en)
NO (1) NO156129C (en)
NZ (1) NZ197081A (en)
PT (1) PT73024B (en)
ZA (1) ZA813176B (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548672A1 (en) * 1983-07-04 1985-01-11 Pharmuka Lab SULPHATE OLIGOSACCHARIDES AND THEIR USE AS MEDICAMENTS
DE3422407A1 (en) * 1984-06-16 1986-03-06 B. Braun Melsungen Ag, 3508 Melsungen USE OF HEPARINE DERIVATIVES FOR SELECTIVE EXTRA-CORPORAL PRECIPITATION OF LOW-DENSITY-LIPOPROTEINS FROM FULL SERUM OR PLASMA
EP0209924A1 (en) * 1985-07-12 1987-01-28 Akzo N.V. New anti-trombosis agent based on glycosaminoglycan, process for its preparation, and pharmaceutical compositions
FR2584728B1 (en) * 1985-07-12 1987-11-20 Choay Sa PROCESS FOR THE SULFATION OF GLYCOSAMINOGLYCANS AND THEIR FRAGMENTS
ES2003197A6 (en) * 1987-01-05 1988-10-16 Rovi Lab Farmaceut Sa Process for the depolymerization of heparin for obtaining heparin with a low molecular weight and having an antithrombotic activity.
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1230582B (en) 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi DERMATAN SULPHATE AND HEPARIN OILGOSACCHARID WITH ANTI-THEROSCLEROTIC ACTIVITIES
IT1234826B (en) * 1989-01-30 1992-05-29 Alfa Wassermann Spa HEPARIN DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION
US5340932A (en) * 1989-08-18 1994-08-23 Ajorca S.A. Substances with heparin-like structure and their method of production
USRE38743E1 (en) * 1990-06-26 2005-06-14 Aventis Pharma S.A. Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
FR2663639B1 (en) * 1990-06-26 1994-03-18 Rhone Poulenc Sante LOW MOLECULAR WEIGHT POLYSACCHARIDE BLENDS PROCESS FOR PREPARATION AND USE.
DE4121115B9 (en) * 1990-06-26 2005-09-29 Aventis Pharma S.A. Mixtures of sulfated polysaccharides with the basic structure of heparin-forming polysaccharides and low molecular weight, their method of preparation and use
US5707973A (en) * 1991-04-23 1998-01-13 Rhone-Poulenc Rorer S.A. Sulfated polysaccharids for treatment or prevention of thromboses
IT1256236B (en) * 1992-12-23 1995-11-29 Mediolanum Farmaceutici Srl OLIGOSACCHARIDES WITH BIOLOGICAL ACTIVITY AND PROCEDURE FOR THEIR PREPARATION OF GLYCOSAMINOGLICANS
ES2077533B1 (en) * 1994-02-28 1996-07-01 Bioiberica PROCEDURE FOR OBTAINING OLIGOSACCHARIDE FRACTIONS BY CHEMICAL DEPOLYMERIZATION OF HEPARIN.
IL129877A (en) * 1996-11-27 2004-08-31 Aventis Pharm Prod Inc PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACITIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
AUPO556297A0 (en) * 1997-03-11 1997-04-10 Australian National University, The Sulfated oligosaccharides having anticoagulant/ antithrombotic activity
JP4897991B2 (en) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ Ultra low molecular weight heparin composition
US6969705B2 (en) 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
FR2811992B1 (en) * 2000-07-21 2003-07-04 Aventis Pharma Sa MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE60218642T2 (en) * 2002-06-20 2007-11-29 Chemi S.P.A., Cinisello Balsamo Process for the preparation of heparin esters
FR2845686B1 (en) * 2002-10-10 2013-08-30 Aventis Pharma Sa MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
JP2006096668A (en) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd Medicine comprising combination of elastase inhibitor with enzyme inhibitor of blood coagulation system and/or fibrinolysis system
DE10260958A1 (en) * 2002-12-20 2004-07-08 Sustech Gmbh & Co. Kg Composite materials made from calcium compounds and polysaccharides containing glucuronic acid and / or iduronic acid
US7956046B2 (en) 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
ITMI20031679A1 (en) * 2003-08-29 2005-02-28 Opocrin Spa PROCESS FOR THE PRODUCTION OF LOW WEIGHT EPARINES
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
US20050261241A1 (en) 2004-05-19 2005-11-24 Celsus Biopharmaceuticals, Inc. Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses
EP1792621B1 (en) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Orally administrable heparin derivatives
ES2340902B1 (en) * 2008-07-01 2011-05-03 Laboratorios Farmaceuticos Rovi, S.A. PHARMACEUTICAL COMPOSITION WITH GLYCAMINOGLYGANS AND ITS USE IN THE TREATMENT OF CHRONIC ULCERAS.
KR101794877B1 (en) * 2010-09-14 2017-11-07 고쿠리츠 다이가쿠 호징 미야자키 다이가쿠 High purity heparin and production method therefor
BR112020011554B1 (en) 2017-12-11 2023-10-17 Biological E Limited ENOXAPARIN SODIUM PREPARATION PROCESS
EP3997238A1 (en) 2019-07-09 2022-05-18 Optimvia, LLC Methods for synthesizing anticoagulant polysaccharides
CN114072430B (en) * 2020-04-27 2023-07-28 罗威制药股份有限公司 Low molecular weight heparin acquisition procedure and low molecular weight heparin obtained
EP4182452A1 (en) 2020-07-14 2023-05-24 Optimvia, LLC Methods for synthesizing non-anticoagulant heparan sulfate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3835112A (en) * 1970-06-08 1974-09-10 Etude Et D Exploit De Marques Heparin esters
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity

Also Published As

Publication number Publication date
AT384428B (en) 1987-11-10
MA19143A1 (en) 1981-12-31
NO811632L (en) 1981-11-16
DZ294A1 (en) 2004-09-13
DK168824B1 (en) 1994-06-20
DK211981A (en) 1981-11-15
IE51283B1 (en) 1986-11-26
FI67865C (en) 1985-06-10
JPS6051482B2 (en) 1985-11-14
IL62866A0 (en) 1981-07-31
FR2482611A1 (en) 1981-11-20
DE3165361D1 (en) 1984-09-13
ATA213681A (en) 1987-04-15
AR229510A1 (en) 1983-09-15
AU7051981A (en) 1981-11-19
IL62866A (en) 1984-06-29
IN152828B (en) 1984-04-14
JPS5710601A (en) 1982-01-20
NO156129B (en) 1987-04-21
ES8206555A1 (en) 1982-08-16
EP0040144B1 (en) 1984-08-08
CA1181744A (en) 1985-01-29
PT73024B (en) 1982-07-01
GR82283B (en) 1984-12-13
ES502199A0 (en) 1982-08-16
NZ197081A (en) 1984-07-31
KR840001753B1 (en) 1984-10-19
HUT34769A (en) 1985-04-28
FI811469L (en) 1981-11-15
ZA813176B (en) 1982-05-26
FI67865B (en) 1985-02-28
PT73024A (en) 1981-06-01
AU535791B2 (en) 1984-04-05
FR2482611B1 (en) 1986-03-07
EP0040144A1 (en) 1981-11-18
HU188667B (en) 1986-05-28
NO156129C (en) 1987-07-29
KR830006333A (en) 1983-09-24

Similar Documents

Publication Publication Date Title
IE811074L (en) Sulphated polysaccharides
ATE60888T1 (en) GEL SYSTEM.
IT1248557B (en) MIXTURES OF LOW MOLECULAR WEIGHT POLYSACCHARIDES, PREPARATION AND USE PROCEDURE.
DK164068C (en) APPLICABLE MIXTURE OF POLYSACCHARIDE AND GELATINE, AXICALLY APPLICABLE PREPARATION AND GEL PREPARED
IL81081A (en) Topical pharmaceutical compositions for promoting wound healing containing synthetic polysulfated mono-and disaccharides
DE3370632D1 (en) Depolymerized and supersulfated heparin, process for its preparation and pharmaceutical compositions containing them
SE8206173D0 (en) NOVEL PLASMINOGEN ACTIVATOR DERIVATIVES
IT8748097A0 (en) PHARMACEUTICAL COMPOSITIONS WITH SYSTEMIC ACTION, TOPICALLY APPLICABLE
DK0380943T3 (en) New heparinic derivatives and methods for their preparation
AR248429A1 (en) N,o-sulfated heparosanes; process to produce the same and pharmaceutical compositions containing them
EP0259037A3 (en) Absorbent resin
IT1254216B (en) POLYSACCHARIDIC DERIVATIVES OF HEPARIN, EPARAN SULPHATE, THEIR FRACTIONS AND FRAGMENTS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES2068969T3 (en) SUPERSULFATED HEPARINES.
DE3581768D1 (en) TENSIDEPRAEPARATE.
ATE119547T1 (en) OLIGOSACCHARIDES WITH ANTIATHEROSCLEROTIC EFFECT.
IT8548506A0 (en) THIOPHENE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DISPERSED DYES (CASE 150-4940)
ATE236933T1 (en) OLIGOSACCHARIDE MIXTURES WITH ANTITHROMBOTIC EFFECT
IT1230116B (en) FURANURONIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICATIONS
MX9203786A (en) SULPHATE GLYCOSAMINOGLYCURONANE WITH ANTI-THROMBOTIC ACTIVITY
IT1200079B (en) NAPHTHOXYZINE DERIVATIVES, THEIR PREPARATION, THEIR APPLICATION AS MEDICATIONS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
IT1147810B (en) DICHLOPROPANCARBOXYLIC ACID DERIVATIVES REPLACED IN POSITION 3 BY A VINYL CHAIN, THEIR PREPARATION PROCEDURE, THEIR APPLICATION AS PERFUMED AGENTS AND COMPOSITIONS CONTAINING THEM
ES8802470A1 (en) New anti-trombosis agent based on glycosaminoglycan, process for its preparation, and pharmaceutical compositions.
ATE14388T1 (en) PRODUCTION OF ZEOLITE HAGGLOMERATES.
IT1157231B (en) MONOSUBSTITUTED DERIVATIVES OF 4-FENYL 4-BONE BUTEN-2-CICO ACID, USEFUL AS MEDICATIONS, AND THE COMPOSITIONS CONTAINING THEM
IT8002107A0 (en) CONNECTED SO AS TO ALLOW THE PROCEDURE FOR THE PRODUCTION OF IMMEDIATE ASSEMBLY AT THE TIME OF A BOX, FOR PACKAGING IN GENERAL USE AND FOR THE PACKAGING OF FRUIT AND VEGETABLE PRODUCTS, MADE UP OF PREFABRICATED SHAPED PANELS AND

Legal Events

Date Code Title Description
SPCF Request for grant of supplementary protection certificate

Free format text: SPC 19/93:19930519

SPCF Request for grant of supplementary protection certificate

Free format text: ERRATUM: SPC 15/93 19/93: THE WORD "ROBER" IN APPLICANTS NAME TO READ: "RORER".

SPCG Supplementary protection certificate granted

Free format text: SPC 19/93 EXPIRES:20020403

MK9A Patent expired